|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 3963 for Mtor

<< First    < Previous  |  Next >    Last >>
0.045s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
29712777 | J:262236
First Author: Umegaki Y
Year: 2018
Journal: J Neurosci
Title: Palladin Is a Neuron-Specific Translational Target of mTOR Signaling That Regulates Axon Morphogenesis.
Volume: 38
Issue: 21
Pages: 4985-4995
•
•
•
•
•
Publication
29867114 | J:289055
First Author: Le Y
Year: 2018
Journal: Cell Death Dis
Title: Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.
Volume: 9
Issue: 6
Pages: 666
•
•
•
•
•
Publication
29636366 | J:263188
First Author: Xiong Y
Year: 2018
Journal: J Lipid Res
Title: Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance.
Volume: 59
Issue: 6
Pages: 974-981
•
•
•
•
•
Publication
28101526 | J:255825
 
First Author: Chen W
Year: 2016
Journal: eNeuro
Title: Rapamycin-Resistant mTOR Activity Is Required for Sensory Axon Regeneration Induced by a Conditioning Lesion.
Volume: 3
Issue: 6
•
•
•
•
•
Publication
21511183 | J:171599
First Author: Li Q
Year: 2011
Journal: Immunity
Title: A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.
Volume: 34
Issue: 4
Pages: 541-53
•
•
•
•
•
Publication
20862226 | J:165117
 
First Author: Ma T
Year: 2010
Journal: PLoS One
Title: Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Volume: 5
Issue: 9
•
•
•
•
•
Publication
27690224 | J:238500
   
First Author: Yang J
Year: 2016
Journal: Elife
Title: Critical roles of mTOR Complex 1 and 2 for T follicular helper cell differentiation and germinal center responses.
Volume: 5
•
•
•
•
•
Publication
31296735 | J:280269
First Author: Vetters J
Year: 2019
Journal: J Exp Med
Title: The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF.
Volume: 216
Issue: 9
Pages: 2010-2023
•
•
•
•
•
Publication
21040901 | J:167537
First Author: Lee JY
Year: 2010
Journal: Cell Stem Cell
Title: mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion.
Volume: 7
Issue: 5
Pages: 593-605
•
•
•
•
•
Publication
33951440 | J:306662
First Author: Li K
Year: 2021
Journal: Cell Rep
Title: mTOR signaling regulates gastric epithelial progenitor homeostasis and gastric tumorigenesis via MEK1-ERKs and BMP-Smad1 pathways.
Volume: 35
Issue: 5
Pages: 109069
•
•
•
•
•
Publication
18468454 | J:136982
First Author: Cao R
Year: 2008
Journal: Mol Cell Neurosci
Title: Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock.
Volume: 38
Issue: 3
Pages: 312-24
•
•
•
•
•
Publication
34453483 | J:310345
First Author: Cabral WA
Year: 2021
Journal: Aging Cell
Title: Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome.
Volume: 20
Issue: 9
Pages: e13457
•
•
•
•
•
Publication
23250913 | J:193290
First Author: Ching JK
Year: 2013
Journal: Hum Mol Genet
Title: mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
Volume: 22
Issue: 6
Pages: 1167-79
•
•
•
•
•
Publication
28758906 | J:247850
First Author: Hino K
Year: 2017
Journal: J Clin Invest
Title: Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
Volume: 127
Issue: 9
Pages: 3339-3352
•
•
•
•
•
Publication
25573665 | J:342284
First Author: Vasheghani F
Year: 2015
Journal: Ann Rheum Dis
Title: PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage.
Volume: 74
Issue: 3
Pages: 569-78
•
•
•
•
•
Publication
34358226 | J:308519
First Author: Alqurashi RS
Year: 2021
Journal: PLoS One
Title: A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis.
Volume: 16
Issue: 8
Pages: e0252282
•
•
•
•
•
Publication
16915281 | J:111744
First Author: Bernardi R
Year: 2006
Journal: Nature
Title: PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Volume: 442
Issue: 7104
Pages: 779-85
•
•
•
•
•
Publication
23444404 | J:197572
First Author: Rosborough BR
Year: 2013
Journal: Blood
Title: Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction.
Volume: 121
Issue: 18
Pages: 3619-30
•
•
•
•
•
Publication
23425014 | J:218147
First Author: Caccamo A
Year: 2013
Journal: Aging Cell
Title: mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Volume: 12
Issue: 3
Pages: 370-80
•
•
•
•
•
Publication
26961412 | J:250172
 
First Author: Matsushita Y
Year: 2016
Journal: Sci Rep
Title: Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.
Volume: 6
Pages: 22991
•
•
•
•
•
Publication
23774212 | J:200612
First Author: Ghosh S
Year: 2013
Journal: Cancer Res
Title: mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss.
Volume: 73
Issue: 16
Pages: 5218-31
•
•
•
•
•
Publication
27048565 | J:259489
First Author: Morales CR
Year: 2016
Journal: Sci Signal
Title: Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Volume: 9
Issue: 422
Pages: ra34
•
•
•
•
•
Publication
18347059 | J:136088
First Author: Yang TT
Year: 2008
Journal: Mol Cell Biol
Title: Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.
Volume: 28
Issue: 10
Pages: 3489-501
•
•
•
•
•
Publication
24504412 | J:211717
First Author: MacDonald EM
Year: 2014
Journal: Dis Model Mech
Title: Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition.
Volume: 7
Issue: 4
Pages: 471-81
•
•
•
•
•
Publication
22058153 | J:181656
First Author: Schramm C
Year: 2012
Journal: Am J Physiol Heart Circ Physiol
Title: The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Volume: 302
Issue: 1
Pages: H231-43
•
•
•
•
•
Publication
26577454 | J:316569
First Author: Madka V
Year: 2016
Journal: Cancer Prev Res (Phila)
Title: Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
Volume: 9
Issue: 1
Pages: 53-62
•
•
•
•
•
Publication
15467718 | J:93907
First Author: Jacinto E
Year: 2004
Journal: Nat Cell Biol
Title: Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.
Volume: 6
Issue: 11
Pages: 1122-8
•
•
•
•
•
Publication
24973821 | J:248728
First Author: Marçais A
Year: 2014
Journal: Nat Immunol
Title: The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
Volume: 15
Issue: 8
Pages: 749-757
•
•
•
•
•
Publication
20060329 | J:157634
First Author: Gulen MF
Year: 2010
Journal: Immunity
Title: The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
Volume: 32
Issue: 1
Pages: 54-66
•
•
•
•
•
Publication
26732600 | J:317925
First Author: Wang X
Year: 2017
Journal: Mol Neurobiol
Title: Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.
Volume: 54
Issue: 1
Pages: 175-187
•
•
•
•
•
Publication
25655438 | J:315898
First Author: Romine J
Year: 2015
Journal: Neurobiol Aging
Title: The proliferation of amplifying neural progenitor cells is impaired in the aging brain and restored by the mTOR pathway activation.
Volume: 36
Issue: 4
Pages: 1716-1726
•
•
•
•
•
Publication
23226562 | J:195684
First Author: Vilà L
Year: 2012
Journal: PLoS One
Title: Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus.
Volume: 7
Issue: 12
Pages: e51118
•
•
•
•
•
Publication
29099279 | J:333874
First Author: Liang Z
Year: 2018
Journal: Autophagy
Title: MTOR signaling is essential for the development of thymic epithelial cells and the induction of central immune tolerance.
Volume: 14
Issue: 3
Pages: 505-517
•
•
•
•
•
Publication
25332234 | J:224314
First Author: Benhamron S
Year: 2015
Journal: Mol Cell Biol
Title: mTOR activation promotes plasma cell differentiation and bypasses XBP-1 for immunoglobulin secretion.
Volume: 35
Issue: 1
Pages: 153-66
•
•
•
•
•
Publication
24068000 | J:219547
First Author: Ma KL
Year: 2013
Journal: Cardiovasc Res
Title: Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Volume: 100
Issue: 3
Pages: 450-60
•
•
•
•
•
Publication
14561707 | J:162300
First Author: Zhang H
Year: 2003
Journal: J Clin Invest
Title: Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
Volume: 112
Issue: 8
Pages: 1223-33
•
•
•
•
•
Publication
22711699 | J:185267
First Author: Winbanks CE
Year: 2012
Journal: J Cell Biol
Title: Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.
Volume: 197
Issue: 7
Pages: 997-1008
•
•
•
•
•
Publication
26884601 | J:260274
First Author: Viel S
Year: 2016
Journal: Sci Signal
Title: TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Volume: 9
Issue: 415
Pages: ra19
•
•
•
•
•
Publication
26683340 | J:316512
 
First Author: Kong B
Year: 2015
Journal: Mol Cancer
Title: Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
Volume: 14
Pages: 212
•
•
•
•
•
Publication
21233250 | J:186008
First Author: Vigneron F
Year: 2011
Journal: Cardiovasc Res
Title: GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Volume: 90
Issue: 1
Pages: 49-56
•
•
•
•
•
Publication
31432191 | J:290470
First Author: Gong J
Year: 2019
Journal: Mol Med Rep
Title: Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
Volume: 20
Issue: 4
Pages: 3240-3248
•
•
•
•
•
Publication
34417330 | J:311735
First Author: Jeffries MA
Year: 2021
Journal: J Neurosci
Title: mTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model.
Volume: 41
Issue: 40
Pages: 8321-8337
•
•
•
•
•
Publication
26092121 | J:225515
First Author: You JS
Year: 2015
Journal: Dis Model Mech
Title: The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice.
Volume: 8
Issue: 9
Pages: 1059-69
•
•
•
•
•
Publication
31668132 | J:294138
First Author: Wang H
Year: 2019
Journal: Virulence
Title: T-cell-specific mTOR deletion in mice ameliorated CD4+ T-cell survival in lethal sepsis induced by severe invasive candidiasis.
Volume: 10
Issue: 1
Pages: 892-901
•
•
•
•
•
Publication
28813526 | J:245632
First Author: Kalim KW
Year: 2017
Journal: PLoS One
Title: mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
Volume: 12
Issue: 8
Pages: e0183266
•
•
•
•
•
Publication
29975682 | J:263684
First Author: Nie X
Year: 2018
Journal: PLoS Genet
Title: mTOR acts as a pivotal signaling hub for neural crest cells during craniofacial development.
Volume: 14
Issue: 7
Pages: e1007491
•
•
•
•
•
Publication
23994476 | J:202846
First Author: Wu JJ
Year: 2013
Journal: Cell Rep
Title: Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.
Volume: 4
Issue: 5
Pages: 913-20
•
•
•
•
•
Publication
21674478 | J:176815
First Author: Benhamron S
Year: 2011
Journal: Eur J Immunol
Title: Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.
Volume: 41
Issue: 8
Pages: 2390-6
•
•
•
•
•
Publication
27760377 | J:255676
First Author: Vogel KR
Year: 2017
Journal: Biochim Biophys Acta
Title: Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Volume: 1863
Issue: 1
Pages: 33-42
•
•
•
•
•
Publication
36440598 | J:332423
 
First Author: Kong X
Year: 2022
Journal: Development
Title: Fine-tuning of mTOR signaling by the UBE4B-KLHL22 E3 ubiquitin ligase cascade in brain development.
Volume: 149
Issue: 24
•
•
•
•
•
Publication
23744272 | J:201333
First Author: Magri L
Year: 2013
Journal: Dis Model Mech
Title: Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models.
Volume: 6
Issue: 5
Pages: 1185-97
•
•
•
•
•
Publication
25792564 | J:224226
First Author: Moore SR
Year: 2015
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Glutamine and alanyl-glutamine promote crypt expansion and mTOR signaling in murine enteroids.
Volume: 308
Issue: 10
Pages: G831-9
•
•
•
•
•
Publication
24939733 | J:215498
First Author: Zhang C
Year: 2014
Journal: Am J Physiol Endocrinol Metab
Title: Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor.
Volume: 307
Issue: 3
Pages: E305-15
•
•
•
•
•
Publication
22473959 | J:183849
First Author: Lee K
Year: 2012
Journal: J Exp Med
Title: Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.
Volume: 209
Issue: 4
Pages: 713-28
•
•
•
•
•
Publication
36334595 | J:332376
First Author: Van Heurck R
Year: 2023
Journal: Neuron
Title: CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors.
Volume: 111
Issue: 1
Pages: 65-80.e6
•
•
•
•
•
Publication
28875936 | J:248330
   
First Author: Marçais A
Year: 2017
Journal: Elife
Title: High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.
Volume: 6
•
•
•
•
•
Publication
28511572 | J:271732
First Author: Jahrling JB
Year: 2018
Journal: J Cereb Blood Flow Metab
Title: mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment.
Volume: 38
Issue: 1
Pages: 58-74
•
•
•
•
•
Publication
20335217 | J:161553
First Author: Turnquist HR
Year: 2010
Journal: Blood
Title: mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.
Volume: 115
Issue: 23
Pages: 4758-69
•
•
•
•
•
Publication
38519468 | J:346995
First Author: Huang N
Year: 2024
Journal: Nat Commun
Title: Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation.
Volume: 15
Issue: 1
Pages: 2598
•
•
•
•
•
Publication
24882582 | J:221270
First Author: Zhao T
Year: 2015
Journal: Oncogene
Title: Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice.
Volume: 34
Issue: 15
Pages: 1938-48
•
•
•
•
•
Publication
21911744 | J:189497
First Author: Velazquez-Garcia S
Year: 2011
Journal: Diabetes
Title: Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation.
Volume: 60
Issue: 10
Pages: 2546-59
•
•
•
•
•
Publication
29351469 | J:261008
First Author: Van Skike CE
Year: 2018
Journal: Am J Physiol Heart Circ Physiol
Title: Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
Volume: 314
Issue: 4
Pages: H693-H703
•
•
•
•
•
Publication
17698586 | J:126769
First Author: Jossin Y
Year: 2007
Journal: Mol Cell Biol
Title: Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.
Volume: 27
Issue: 20
Pages: 7113-24
•
•
•
•
•
Publication
22056141 | J:177840
First Author: Magri L
Year: 2011
Journal: Cell Stem Cell
Title: Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
Volume: 9
Issue: 5
Pages: 447-62
•
•
•
•
•
Publication
12150926 | J:161033
First Author: Hara K
Year: 2002
Journal: Cell
Title: Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.
Volume: 110
Issue: 2
Pages: 177-89
•
•
•
•
•
Publication
24209762 | J:205532
First Author: Wang S
Year: 2013
Journal: Cell Stem Cell
Title: Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency.
Volume: 13
Issue: 5
Pages: 617-25
•
•
•
•
•
Publication
14579029 | J:87110
First Author: Gual P
Year: 2003
Journal: Diabetologia
Title: MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632.
Volume: 46
Issue: 11
Pages: 1532-42
•
•
•
•
•
Publication
24917592 | J:259187
First Author: Hamilton KS
Year: 2014
Journal: Sci Signal
Title: T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
Volume: 7
Issue: 329
Pages: ra55
•
•
•
•
•
Publication
31441226 | J:343934
First Author: Huang WC
Year: 2019
Journal: Autism Res
Title: Genetic Suppression of mTOR Rescues Synaptic and Social Behavioral Abnormalities in a Mouse Model of Pten Haploinsufficiency.
Volume: 12
Issue: 10
Pages: 1463-1471
•
•
•
•
•
Publication
27133769 | J:251023
 
First Author: Mazelin L
Year: 2016
Journal: J Mol Cell Cardiol
Title: mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis.
Volume: 97
Pages: 213-25
•
•
•
•
•
Publication
16537399 | J:107663
First Author: Hornberger TA
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle.
Volume: 103
Issue: 12
Pages: 4741-6
•
•
•
•
•
Publication
26491103 | J:242391
First Author: Rosario FJ
Year: 2016
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth.
Volume: 310
Issue: 1
Pages: R87-93
•
•
•
•
•
Publication
24567410 | J:328676
First Author: Hoshii T
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
Volume: 111
Issue: 10
Pages: 3805-10
•
•
•
•
•
Publication
27281705 | J:236498
First Author: Boyer A
Year: 2016
Journal: Biol Reprod
Title: mTOR Regulates Gap Junction Alpha-1 Protein Trafficking in Sertoli Cells and Is Required for the Maintenance of Spermatogenesis in Mice.
Volume: 95
Issue: 1
Pages: 13
•
•
•
•
•
Publication
27618784 | J:238760
First Author: Dominick G
Year: 2017
Journal: Aging Cell
Title: mTOR regulates the expression of DNA damage response enzymes in long-lived Snell dwarf, GHRKO, and PAPPA-KO mice.
Volume: 16
Issue: 1
Pages: 52-60
•
•
•
•
•
Publication
24002653 | J:210710
First Author: Goodman CA
Year: 2013
Journal: Mol Endocrinol
Title: Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Volume: 27
Issue: 11
Pages: 1946-57
•
•
•
•
•
Publication
20060330 | J:157633
First Author: Rao RR
Year: 2010
Journal: Immunity
Title: The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.
Volume: 32
Issue: 1
Pages: 67-78
•
•
•
•
•
Publication
22729283 | J:197585
First Author: Xian L
Year: 2012
Journal: Nat Med
Title: Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.
Volume: 18
Issue: 7
Pages: 1095-101
•
•
•
•
•
Publication
23183047 | J:194209
First Author: Finlay DK
Year: 2012
Journal: J Exp Med
Title: PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
Volume: 209
Issue: 13
Pages: 2441-53
•
•
•
•
•
Publication
19541609 | J:150834
First Author: Shackelford DB
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
Volume: 106
Issue: 27
Pages: 11137-42
•
•
•
•
•
Publication
33323119 | J:302571
First Author: Casingal CR
Year: 2020
Journal: Mol Brain
Title: Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.
Volume: 13
Issue: 1
Pages: 167
•
•
•
•
•
Publication
28875501 | J:256597
First Author: Yang CS
Year: 2017
Journal: Prostate
Title: The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.
Volume: 77
Issue: 15
Pages: 1452-1467
•
•
•
•
•
Publication
24141387 | J:208728
First Author: Keating R
Year: 2013
Journal: Nat Immunol
Title: The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.
Volume: 14
Issue: 12
Pages: 1266-76
•
•
•
•
•
Publication
27278932 | J:319202
First Author: de Stephanis L
Year: 2017
Journal: Clin Exp Nephrol
Title: Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
Volume: 21
Issue: 2
Pages: 203-211
•
•
•
•
•
Publication
28751568 | J:269272
First Author: Jiao Y
Year: 2017
Journal: Arterioscler Thromb Vasc Biol
Title: mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.
Volume: 37
Issue: 9
Pages: 1657-1666
•
•
•
•
•
Publication
29175333 | J:272444
First Author: Peng H
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells.
Volume: 495
Issue: 1
Pages: 1129-1135
•
•
•
•
•
Publication
16221682 | J:104099
First Author: Hresko RC
Year: 2005
Journal: J Biol Chem
Title: mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.
Volume: 280
Issue: 49
Pages: 40406-16
•
•
•
•
•
Publication
23440873 | J:196068
First Author: Kogasaka Y
Year: 2013
Journal: Mol Reprod Dev
Title: Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice.
Volume: 80
Issue: 4
Pages: 334-48
•
•
•
•
•
Publication
23803853 | J:200609
First Author: Pourdehnad M
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers.
Volume: 110
Issue: 29
Pages: 11988-93
•
•
•
•
•
Publication
19457267 | J:259585
 
First Author: Shor B
Year: 2009
Journal: BMC Immunol
Title: A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.
Volume: 10
Pages: 28
•
•
•
•
•
Publication
12718876 | J:237685
First Author: Kim DH
Year: 2003
Journal: Mol Cell
Title: GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.
Volume: 11
Issue: 4
Pages: 895-904
•
•
•
•
•
Publication
20852388 | J:165260
First Author: Qin S
Year: 2010
Journal: J Clin Invest
Title: Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.
Volume: 120
Issue: 10
Pages: 3617-28
•
•
•
•
•
Publication
29191093 | J:341807
First Author: Yamane T
Year: 2018
Journal: Biosci Biotechnol Biochem
Title: Branched-chain amino acids regulate type I tropocollagen and type III tropocollagen syntheses via modulation of mTOR in the skin.
Volume: 82
Issue: 4
Pages: 611-615
•
•
•
•
•
Publication
17635924 | J:124932
First Author: Gelinas JN
Year: 2007
Journal: J Biol Chem
Title: ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation.
Volume: 282
Issue: 37
Pages: 27527-35
•
•
•
•
•
Publication
19255143 | J:148419
First Author: Distefano G
Year: 2009
Journal: Mol Cell Biol
Title: Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.
Volume: 29
Issue: 9
Pages: 2359-71
•
•
•
•
•
Publication
16963469 | J:114898
First Author: Mavrakis M
Year: 2006
Journal: Hum Mol Genet
Title: Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
Volume: 15
Issue: 19
Pages: 2962-71
•
•
•
•
•
Publication
28626016 | J:245047
First Author: Al-Ali H
Year: 2017
Journal: J Neurosci
Title: The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.
Volume: 37
Issue: 30
Pages: 7079-7095
•
•
•
•
•
Publication
23341605 | J:193828
First Author: Chang J
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling.
Volume: 110
Issue: 6
Pages: 2270-5
•
•
•
•
•
Publication
24218567 | J:202964
First Author: Lai LP
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.
Volume: 110
Issue: 48
Pages: 19450-5
•
•
•
•
•
Publication
34052210 | J:309998
 
First Author: Nie X
Year: 2021
Journal: Dev Biol
Title: mTOR deletion in neural crest cells disrupts cardiac outflow tract remodeling and causes a spectrum of cardiac defects through the mTORC1 pathway.
Volume: 477
Pages: 241-250
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom